![Keri Lantz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Keri Lantz
Nessuna posizione attualmente
Profilo
Keri Lantz formerly worked at Achillion Pharmaceuticals, Inc., as Chief Financial & Accounting Officer in 2019.
Ms. Lantz received her undergraduate degree from Central Connecticut State University.
Precedenti posizioni note di Keri Lantz
Società | Posizione | Fine |
---|---|---|
ACHILLION PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 11/02/2019 |
Formazione di Keri Lantz
Central Connecticut State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Società collegate
Aziende private | 1 |
---|---|
Achillion Pharmaceuticals, Inc.
![]() Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Borsa valori
- Insiders
- Keri Lantz